Attardi, G., Amaldi, F.: Structure and synthesis of ribosomal RNA. Ann. Rev. Biochem.39, 183–226 (1970).
Billiau, A., Muyembe, J. J., de Somer, P.: Mechanism of antiviral activityin vivo of polycarboxylates which induce interferon production. Nature (New Biol.)232, 183–186 (1971).
Fukada, T., Kawade, Y., Ujihara, M., Shin, C., Shima, T.: Interference with virus infection induced by RNA in chick embryo cells. Jap. J. Microbiol.12, 329–341 (1968).
Hagenbuchle, O., Sauter, M., Argetsinger-Steitz, J., Maus, R. J.: Conservation of the primary structure at the 3′ end of 18S rRNA from eukaryotic cells. Cell13, 551–563 (1978).
Loening, U. E.: The determination of the molecular weight of ribonucleic acid by polyacrylamide gel electrophoresis. Biochem. J.113, 131–138 (1969).
Murakami, W. T.: Fractionation of RNAs on MAK columns. Methods in Enzymology12 A, 634–637 (1967).
Palmiter, R. D.: Ovalbumin messenger ribonucleic acid translation. J. biol. Chem.248, 2095–2106 (1973).
Peto, R., Pike, M. C.: Conservatism of the approximation ∑ (0-E)2/E in the logrank test for survival data or tumour incidence data. Biometrics29, 579–584 (1973).
Rushizky, G. W., Bartos, E. M., Sober, H. A.: Chromotography of mixed oligonucleotides on DEAE-Sephadex. Biochem.3, 626–629 (1964).
Samols, D. R., Hagenbuchle, O., Gage, L. P.: Homology of the 3′ terminal sequences of the 18S rRNA ofBombyx mori and the 16S rRNA ofEscherichia coli. Nucleic Acid Res.7, 1109–1119 (1979).
Shine, J., Dalgarno, L.: The 3′-terminal sequence ofEscherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc. Natl. Acad. Sci. U.S.A.71, 1342–1346 (1974).
Stebbing, N.: Protection of mice against infection with wild-type Mengo virus and an interferon sensitive mutant (IS-1) by polynucleotides and interferons. J. gen. Virol.44, 255–260 (1979).
Stebbing, N., Grantham, C. A., Carey, N.: Antiviral activity of single stranded homopolynucleotides against Encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction. J. gen. Virol.30, 21–39 (1976).
Stebbing, N., Grantham, C. A., Kaminski, F., Lindley, I. J. D.: Protection of mice against Encephalomyocarditis virus infection by preparations of transfer RNA. J. gen. Virol.34, 73–85 (1977).
Stebbing, N., Grantham, C. A., Lindley, I. J. D., Eaton, M. A. W., Carey, N. H.:In vivo antiviral activity of polynucleotide mimics of strategic regions in viral RNA. Ann. N.Y. Acad. Sci.284, 682–696 (1977).
Stebbing, N., Lindley, I. J. D., Eaton, M. A. W.: The direct antiviral activity of single-stranded polyribonucleotides. II. The effect of molecular size and the involvement of cellular receptors. Proc. Roy. Soc. London, Ser. B198, 429–437 (1977).
Steitz, J. A., Jakes, K.: How ribosomes select initiator regions in mRNA: Base pair formation between with 3′ terminus of 16S rRNA and the mRNA during initiation of protein synthesis inEscherichia coli. Proc. Natl. Acad. Sci. U.S.A.72, 4734–4738 (1975).
Takano, K., Warren, J., Jensen, K. E., Neal, A. L.: Nucleic acid-induced resistance to viral infection. J. Bacteriol.90, 1542–1547 (1965).